XIX International AIDS Conference in Washington D.C. Interview with Seyed Ramin-Radfar from Tehran, Iran. He is part of IAS-NIDA Fellowship on HIV and drug use.

XIX International AIDS Conference in Washington D.C. Interview with Saekuul Islam from the National University in Dakha, in Bangladesh. He is part of the IAS-NIDA Fellowship on HIV and drug use.

XIX International AIDS Conference in Wasington D.C. Interview with Makhbatsho Bakhromow from Prisma Research Center in Tajikistan. He is part of IAS-NIDA Fellowship on HIV and Drug Use.

XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

XIX International AIDS Conference. Interview with Shomyseh Sanjabi who is a basic Immunlogist at Gladstone Institutes. She tells about their animal model studies of HIV transmission and ageing with HIV. She is part of the CNIHR program.

XIX International AIDS Conference in Washington D.C. Interview with Takayuki Ota from The Scripps Research Institute in La Hoia, San Diego. He is part of the Creative and Novel Ideas in HIV Research Grants Program (CNIHR), a IAS and NIH collaboration.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

XIX International AIDS Conference. Gretchen Neigh is a neurologist at Emory University in Atlanta working with basic research on depression. She tells about her current work on depression in HIV positive rats and her future hopes for research in humans.

XIX International AIDS Conference. Interview with the Immunologist Michael Elliot from University of Rochester on the CNIHR program which involves scientist not previously engaged in the HIV research field to develop new thinking withing the field.

XVIII International AIDS Conference in Vienna. Interview with Richard Marlink, Professor at Harvard School of Public Health. He talks about a symposium on the history of HIV/AIDS and future strategies for ending AIDS, that was planned in Boston in 2011.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Michelle Adato and Stuart Gillespie from the International Food Policy Research Institute (IFPRI) talk about how food security work can help decreasing poverty, prevent HIV and maintain the effect of ARV treatment.